Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Midori Kjellin, Hege Kileng, Dario Akaberi, Navaneethan Palanisamy, Ann-Sofi Duberg, Astrid Danielsson, Magnhild Gangsøy Kristiansen, Johan Nöjd, Soo Aleman, Tore Gutteberg, Rasmus Goll, Anders Lannergård & Johan Lennerstrand. (2019) Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment: real-life experience from a multicenter study in Sweden and Norway. Scandinavian Journal of Gastroenterology 54:8, pages 1042-1050.
Read now
Read now
Hege Kileng, Midori Kjellin, Dario Akaberi, Assar Bergfors, Ann-Sofi Duberg, Lars Wesslén, Astrid Danielsson, Magnhild Gangsøy Kristiansen, Tore Gutteberg, Rasmus Goll, Anders Lannergård & Johan Lennerstrand. (2018) Personalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014–2016: a study of treatment outcome in patients with or without resistance-based DAA-therapy. Scandinavian Journal of Gastroenterology 53:10-11, pages 1347-1353.
Read now
Read now
Bjarte Fosby, Espen Melum, Kristian Bjøro, William Bennet, Allan Rasmussen, Ina Marie Andersen, Maria Castedal, Michael Olausson, Christina Wibeck, Mette Gotlieb, Henrik Gjertsen, Leena Toivonen, Stein Foss, Heikki Makisalo, Arno Nordin, Truls Sanengen, Annika Bergquist, Marie E. Larsson, Gunnar Soderdahl, Greg Nowak, Kirsten Muri Boberg, Helena Isoniemi, Susanne Keiding, Aksel Foss, Pål-Dag Line, Styrbjörn Friman, Erik Schrumpf, Bo-Göran Ericzon, Krister Höckerstedt & Tom H. Karlsen. (2015) Liver transplantation in the Nordic countries – An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982–2013. Scandinavian Journal of Gastroenterology 50:6, pages 797-808.
Read now
Read now
Kyrre H. Toresen, Ivar Mjåland Salte, Steinar Skrede, Roy Miodini Nilsen & Rafael Alexander Leiva. (2014) Clinical outcomes in a cohort of anti-hepatitis C virus-positive patients with significant barriers to treatment referred to a Norwegian outpatient clinic. Scandinavian Journal of Gastroenterology 49:4, pages 465-472.
Read now
Read now
Lars Haukali Omland, Merete Osler, Peter Jepsen, Henrik Krarup, Nina Weis, Peer Brehm Christensen, Casper Roed, Henrik Toft Sørensen & Niels Obel. (2013) Socioeconomic status in HCV infected patients – risk and prognosis. Clinical Epidemiology 5, pages 163-172.
Read now
Read now
Espen Melum, Erik Schrumpf & Kristian Bjøro. (2006) Liver TX for hepatitis C cirrhosis in a low prevalence population: Risk factors and status at evaluation. Scandinavian Journal of Gastroenterology 41:5, pages 592-596.
Read now
Read now
Articles from other publishers (46)
Paul G. Carty, Conor Teljeur, Cillian F. De Gascun, Paddy Gillespie, Patricia Harrington, Aiden McCormick, Michelle O’Neill, Susan M. Smith & Mairin Ryan. (2022) Another Step Toward Hepatitis C Elimination: An Economic Evaluation of an Irish National Birth Cohort Testing Program. Value in Health 25:12, pages 1947-1957.
Crossref
Crossref
Raisa Hannula, Jonas Söderholm, Therese Svendsen, Maja Skaland, Svein A. Nordbø, Harald Steinum & Jan K. Damås. (2021) Hepatitis C outreach project and cross-sectional epidemiology in high-risk populations in Trondheim, Norway. Therapeutic Advances in Infectious Disease 8, pages 204993612110539.
Crossref
Crossref
Luk Van Baelen & Johan Van der Heyden. (2021) Hepatitis C virus prevalence in Belgium. Experimental Results 2.
Crossref
Crossref
Nor Asiah Muhamad, Rimah Melati Ab.Ghani, Mohd Hatta Abdul Mutalip, Eida Nurhadzira Muhammad, Hasmah Mohamad Haris, Rozainanee Mohd Zain, Noraidatulakma Abdullah, Nor Azila Muhammad Azami, Nazihah Abd Jalal, Norliza Ismail, Nurul Ain Mhd Yusuf, Raihannah Othman, Azwa Shawani Kamalul Arifin, Mohd Shaharom Abdullah, Mohd Arman Kamaruddin, Muhammad Radzi Abu Hassan, Tahir Aris & Rahman Jamal. (2020) Seroprevalence of hepatitis B virus and hepatitis C virus infection among Malaysian population. Scientific Reports 10:1.
Crossref
Crossref
Carl Michael Baravelli, Sverre Sandberg, Aasne Karine Aarsand & Mette Christophersen Tollånes. (2019) Porphyria cutanea tarda increases risk of hepatocellular carcinoma and premature death: a nationwide cohort study. Orphanet Journal of Rare Diseases 14:1.
Crossref
Crossref
Ole Jørgen Lygren, Ronny Bjørnestad, Else-Marie Løberg, Martine Lepsøy Bonnier, Vibeke Bråthen Buljovcic, Kjell Arne Johansson & Lars T. Fadnes. (2019) Peer involvement and cross-sector efforts in establishing integrated treatment of hepatitis C virus infection for people with substance use disorders: experiences from Norway. Substance Abuse Treatment, Prevention, and Policy 14:1.
Crossref
Crossref
H. Kileng, T. Gutteberg, R. Goll & E. J. Paulssen. (2019) Screening for hepatitis C in a general adult population in a low-prevalence area: the Tromsø study. BMC Infectious Diseases 19:1.
Crossref
Crossref
Kelly Safreed-Harmon, Sarah Blach, Soo Aleman, Signe Bollerup, Graham Cooke, Olav Dalgard, John F Dillon, Gregory J Dore, Ann-Sofi Duberg, Jason Grebely, Knut Boe Kielland, Håvard Midgard, Kholoud Porter, Homie Razavi, Mark Tyndall, Nina Weis & Jeffrey V Lazarus. (2019) The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward Elimination. Clinical Infectious Diseases 69:12, pages 2218-2227.
Crossref
Crossref
Amber R. Tierney, William Huepfel, Aasma P. Shaukat, John R. Lake, Mark Boldt, Qi Wang & Mohamed A. Hassan. (2018) Direct-Acting Antiviral Therapy for Hepatitis C Infection in a Large Immigrant Community. Journal of Immigrant and Minority Health 21:3, pages 549-554.
Crossref
Crossref
Bernard Luke Edmunds, Emma Ruth Miller & George Tsourtos. (2019) RETRACTED ARTICLE: The distribution and socioeconomic burden of Hepatitis C virus in South Australia: a cross-sectional study 2010–2016. BMC Public Health 19:1.
Crossref
Crossref
Torbjørn Wisløff, Richard White, Olav Dalgard, Ellen J. Amundsen, Hinta Meijerink, Astrid Louise Løvlie & Hilde Kløvstad. (2018) Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway. PharmacoEconomics 36:5, pages 591-601.
Crossref
Crossref
Rujipat Wasitthankasem, Preeyaporn Vichaiwattana, Nipaporn Siripon, Nawarat Posuwan, Chompoonut Auphimai, Sirapa Klinfueng, Napha Thanetkongtong, Viboonsak Vuthitanachot, Supapith Saiyatha, Chaiwat Thongmai, Saowakon Sochoo, Natnada Pongsuwan, Kittiyod Poovorawan, Pisit Tangkijvanich & Yong Poovorawan. (2018) Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, a population-based study. PLOS ONE 13:4, pages e0196301.
Crossref
Crossref
Benedikte Bjøro, Olav Dalgard, Håvard Midgard, Hans Verbaan, Milada Cvancarova Småstuen & Tone Rustøen. (2018) Increased hope following successful treatment for hepatitis C infection. Journal of Advanced Nursing 74:3, pages 724-733.
Crossref
Crossref
H. Kileng, L. Bernfort, T. Gutteberg, O.S. Moen, M.G. Kristiansen, E.J. Paulssen, L.K. Berg, J. Florholmen & R. Goll. (2017) Future complications of chronic hepatitis C in a low-risk area: projections from the hepatitis c study in Northern Norway. BMC Infectious Diseases 17:1.
Crossref
Crossref
Hinta Meijerink, Richard A White, Astrid Løvlie, Birgitte Freiesleben de Blasio, Olav Dalgard, Ellen J. Amundsen, Espen Melum & Hilde Kløvstad. (2017) Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973–2030. BMC Infectious Diseases 17:1.
Crossref
Crossref
Hannes Hagström. (2017) Alcohol, smoking and the liver disease patient. Best Practice & Research Clinical Gastroenterology 31:5, pages 537-543.
Crossref
Crossref
Hannes Hagström. (2017) Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?. Current Hepatology Reports 16:2, pages 152-157.
Crossref
Crossref
Filomena Morisco, Ilaria Loperto, Tommaso Stroffolini, Flavia Lucia Lombardo, Valentina Cossiga, Maria Guarino, Alessia De Feo & Nicola Caporaso. (2017) Prevalence and risk factors of HCV infection in a metropolitan area in southern Italy: Tail of a cohort infected in past decades. Journal of Medical Virology 89:2, pages 291-297.
Crossref
Crossref
Eleni Papachristou, Aikaterini Tsagkovits, Assimina Zavitsanou, Angelos Hatzakis & Dimitrios Paraskevis. (2016) HCV dispersal patterns among intravenous drug users (IDUs) in Athens metropolitan area. Infection, Genetics and Evolution 45, pages 415-419.
Crossref
Crossref
Christine C. Hsu & Kris V. Kowdley. (2016) The Effects of Alcohol on Other Chronic Liver Diseases. Clinics in Liver Disease 20:3, pages 581-594.
Crossref
Crossref
Tatsuo Miyamura. 2016. Hepatitis C Virus II. Hepatitis C Virus II
347
368
.
Tatjana Vilibic-Cavlek. (2015) Epidemiology of hepatitis C in Croatia in the European context. World Journal of Gastroenterology 21:32, pages 9476.
Crossref
Crossref
V. Saraswat, S. Norris, R. J. de Knegt, J. F. Sanchez Avila, M. Sonderup, E. Zuckerman, P. Arkkila, C. Stedman, S. Acharya, I. Aho, A. C. Anand, M. I. Andersson, V. Arendt, O. Baatarkhuu, K. Barclay, Z. Ben-Ari, C. Bergin, F. Bessone, S. Blach, N. Blokhina, C. R. Brunton, G. Choudhuri, V. Chulanov, L. Cisneros, E. A. Croes, Y. A. Dahgwahdorj, O. Dalgard, J. R. Daruich, N. R. Dashdorj, D. Davaadorj, M. de Vree, C. Estes, R. Flisiak, A. C. Gadano, E. Gane, W. Halota, A. Hatzakis, C. Henderson, P. Hoffmann, J. Hornell, D. Houlihan, S. Hrusovsky, P. Jarčuška, D. Kershenobich, K. Kostrzewska, P. Kristian, M. Leshno, Y. Lurie, A. Mahomed, N. Mamonova, N. Mendez-Sanchez, J. Mossong, E. Nurmukhametova, P. Nymadawa, M. Oltman, J. Oyunbileg, Ts. Oyunsuren, G. Papatheodoridis, N. Pimenov, N. Prabdial-Sing, M. Prins, P. Puri, S. Radke, A. Rakhmanova, H. Razavi, K. Razavi-Shearer, H. W. Reesink, E. Ridruejo, R. Safadi, O. Sagalova, R. Sanduijav, I. Schréter, C. Seguin-Devaux, S. R. Shah, I. Shestakova, A. Shevaldin, O. Shibolet, S. Sokolov, K. Souliotis, C. W. Spearman, T. Staub, E. A. Strebkova, D. Struck, K. Tomasiewicz, L. Undram, A. J. van der Meer, D. van Santen, I. Veldhuijzen, F. G. Villamil, S. Willemse, F. R. Zuure, M. O. Silva, V. Sypsa & E. Gower. (2015) Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2. Journal of Viral Hepatitis 22, pages 6-25.
Crossref
Crossref
Suraj A. Sharma & Jordan J. Feld. (2014) Acute Hepatitis C: Management in the Rapidly Evolving World of HCV. Current Gastroenterology Reports 16:2.
Crossref
Crossref
Filippo Ansaldi. (2014) Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy. World Journal of Gastroenterology 20:29, pages 9633.
Crossref
Crossref
Behzad Hajarizadeh, Jason Grebely & Gregory J. Dore. (2013) Epidemiology and natural history of HCV infection. Nature Reviews Gastroenterology & Hepatology 10:9, pages 553-562.
Crossref
Crossref
Hamish A. Innes, Sharon J. Hutchinson, Stephen Barclay, Elaine Cadzow, John F. Dillon, Andrew Fraser, David J. Goldberg, Peter R. Mills, Scott A. McDonald, Judith Morris, Adrian Stanley & Peter Hayes. (2013) Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: Implications for treatment cost-effectiveness. Hepatology 57:2, pages 451-460.
Crossref
Crossref
Knut Boe Kielland, Kjell Skaug, Ellen J. Amundsen & Olav Dalgard. (2013) All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: A controlled study. Journal of Hepatology 58:1, pages 31-37.
Crossref
Crossref
Peer Brehm Christensen, Gordon Hay, Peter Jepsen, Lars Haukali Omland, Søren Andreas Just, Henrik Bygum Krarup, Nina Weis, Niels Obel & Susan Cowan. (2012) Hepatitis C prevalence in Denmark -an estimate based on multiple national registers. BMC Infectious Diseases 12:1.
Crossref
Crossref
Julia Uhanova, Robert B Tate, Douglas J Tataryn & Gerald Y Minuk. (2012) A population-based study of the epidemiology of hepatitis C in a North American population. Journal of Hepatology 57:4, pages 736-742.
Crossref
Crossref
Arne Nørgaard Eskesen, Espen Melum, Amir Moghaddam, Kristian Bjøro, Hans Verbaan, Helmer Ring-Larsen & Olav Dalgard. (2012) Genetic variants at the ITPA locus protect against ribavirin-induced hemolytic anemia and dose reduction in an HCV G2/G3 cohort. European Journal of Gastroenterology & Hepatology 24:8, pages 890-896.
Crossref
Crossref
Nana Wu, Qinjuan Ge, Qingchuan Feng, Jun Zhang, Xiaoxia Liu, Caihong Sun, Yongkang Xu, Guangli He & Chiyu Zhang. (2011) High Prevalence of Hepatitis C virus Among Injection Drug Users in Zhenjiang, Jiangsu, China. Indian Journal of Virology 22:2, pages 77-83.
Crossref
Crossref
Andréa do Livramento, Caio Mauricio Mendes de Cordova, Celso Spada & Arício Treitinger. (2011) Seroprevalence of hepatitis B and C infection markers among children and adolescents in the southern Brazilian region. Revista do Instituto de Medicina Tropical de São Paulo 53:1, pages 13-17.
Crossref
Crossref
Olav Dalgard, Zbigniew Konopski, Franziskus Bosse, Berit Nordstrand, Per Sandvei, Lars Karlsen, Jon Florholmen, Astrid Rojahn, Rune Almaas, Steinar Skrede, Arne Eskesen & Bjørn Myrvang. (2011) Hepatitt C - utredning og behandling. Tidsskrift for Den norske legeforening 131:1, pages 2-9.
Crossref
Crossref
Christine Meffre, Yann Le Strat, Elisabeth Delarocque‐Astagneau, Fréderic Dubois, Denise Antona, Jean‐Marie Lemasson, Josiane Warszawski, Josiane Steinmetz, Dominique Coste, Jean‐François Meyer, Sandrine Leiser, Jean‐Pierre Giordanella, René Gueguen & Jean‐Claude Desenclos. (2010) Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: Social factors are important predictors after adjusting for known risk factors. Journal of Medical Virology 82:4, pages 546-555.
Crossref
Crossref
Øistein Kristensen, Anders Sundøy, Karin Skeie, John-Kåre Vederhus, Ingebjørg Øye, Anne Opsal, Ole Rysstad & Frode Gallefoss. (2009) Korttids hepatitt C-behandling av heroinavhengige pasienter. Tidsskrift for Den norske legeforening 129:16, pages 1639-1642.
Crossref
Crossref
Olav Dalgard & Steinar Skrede. (2009) Opiatavhengige LAR-pasienter bør behandles for hepatitt C. Tidsskrift for Den norske legeforening 129:23, pages 2498-2499.
Crossref
Crossref
Hla-Hla Thein, Qilong Yi, Gregory J. Dore & Murray D. Krahn. (2008) Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression. Hepatology 48:2, pages 418-431.
Crossref
Crossref
Juan I. Esteban, Silvia Sauleda & Josep Quer. (2008) The changing epidemiology of hepatitis C virus infection in Europe. Journal of Hepatology 48:1, pages 148-162.
Crossref
Crossref
Espen Melum, Styrbjörn Friman, Kristian Bjøro, Allan Rasmussen, Helena Isoniemi, Henrik Gjertsen, Lars Bäckman, Antti Oksanen, Michael Olausson, Frans F. Duraj & Bo-Göran Ericzon. (2007) Hepatitis C impairs survival following liver transplantation irrespective of concomitant hepatocellular carcinoma. Journal of Hepatology 47:6, pages 777-783.
Crossref
Crossref
G.G.G. Baaten, G.J.B. Sonder, N.H.T.M. Dukers, R.A. Coutinho & J.A.R. Van den Hoek. (2007) Population-based study on the seroprevalence of hepatitis A, B, and C virus infection in Amsterdam, 2004. Journal of Medical Virology 79:12, pages 1802-1810.
Crossref
Crossref
Aud L. Krook, Dorthe Stokka, Bernt Heger & Egil Nygaard. (2007) Hepatitis C Treatment of Opioid Dependants Receiving Maintenance Treatment: Results of a Norwegian Pilot Study. European Addiction Research 13:4, pages 216-221.
Crossref
Crossref
H. Gjertsen, O. Weiland, A. Oksanen, G. Söderdahl, U. Broomé & B.-G. Ericzon. (2006) Liver Transplantation for HCV Cirrhosis at Karolinska University Hospital Huddinge, Stockholm. Transplantation Proceedings 38:8, pages 2675-2676.
Crossref
Crossref
A. Moghaddam, N. Reinton & O. Dalgard. (2006) A rapid real-time PCR assay for determination of hepatitis C virus genotypes 1, 2 and 3a. Journal of Viral Hepatitis 13:4, pages 222-229.
Crossref
Crossref
Colin W Shepard, Lyn Finelli & Miriam J Alter. (2005) Global epidemiology of hepatitis C virus infection. The Lancet Infectious Diseases 5:9, pages 558-567.
Crossref
Crossref
Olav Dalgard. (2005) Follow‐Up Studies of Treatment for Hepatitis C Virus Infection among Injection Drug Users. Clinical Infectious Diseases 40:s5, pages S336-S338.
Crossref
Crossref